Allergan

AbbVie has long been under pressure to diversify its portfolio and its shares have lost more than a third of their value since…

The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA. It also comprises complex generic…

The decision to call off the merger came after the US Treasury Department announced new rules to discourage mergers between US and…